Is taro.com Safe? Security Analysis for Taro Pharmaceutical Industries Ltd.
Check if taro.com is a scam or legitimate. Free security scan and reviews.
AI Summary
Taro Pharmaceutical Industries Ltd. is a well-established pharmaceutical company specializing in topical prescription products and other pharmaceutical offerings. The company is now a wholly owned subsidiary of Sun Pharma, a global healthcare leader. The website reflects a corporate presence with sections dedicated to products, research, investor relations, and affiliated sites. The target audience includes healthcare professionals, investors, and consumers seeking pharmaceutical products. The business model focuses on pharmaceutical manufacturing, research, and distribution with a strong market position supported by its parent company Sun Pharma. Technically, the website is built on Drupal 7 with legacy jQuery libraries and uses several JavaScript plugins for UI components. The site is moderately optimized for mobile devices and has a good design and navigation structure. However, some technical debt is evident due to outdated libraries and lack of modern security headers. Hosting appears to be managed with AT&T DNS services, and no advanced analytics or tracking services were detected. From a security perspective, the site uses HTTPS (implied by the domain and typical corporate practice), but lacks DNSSEC and security headers. The WHOIS data shows a long-established domain with appropriate domain locks, indicating legitimacy. No explicit security or incident response policies are published, and no vulnerability disclosure or security.txt files were found. The site lacks a cookie consent mechanism, which may impact privacy compliance. Overall, the website is professional and trustworthy but could improve its security posture and privacy compliance. Strategic recommendations include upgrading outdated libraries, enabling DNSSEC, implementing security headers, and adding cookie consent mechanisms to enhance user trust and regulatory compliance.
Detected Technologies
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
Taro Pharmaceutical Industries operates in the healthcare sector with a focus on pharmaceutical manufacturing and research. Its ownership by Sun Pharma positions it strongly in the global pharmaceutical market. The company maintains multiple subsidiaries targeting different geographic markets including the USA, Canada, Israel, and international markets. The website supports investor relations and corporate communications, indicating a transparent and mature business model. The partnership ecosystem includes Sun Pharma and affiliated companies like Chattem Chemicals. The company targets healthcare professionals, investors, and consumers, leveraging its research capabilities and product portfolio to maintain competitive advantage. Growth indicators include recent merger announcements and active investor communications.
Security Posture Analysis
Comprehensive Security Assessment
The current security posture is moderate but with notable gaps. The domain is secured with transfer and update prohibitions, indicating good domain management. However, the absence of DNSSEC and security headers reduces protection against DNS spoofing and common web attacks. The use of outdated jQuery 1.7.2 introduces potential vulnerabilities. No public security or incident response policies are available, and no dedicated security contact channels were found. Privacy compliance is partial, lacking cookie consent mechanisms. Overall, the site is functional and legitimate but requires improvements to meet modern security and privacy standards.
Strategic Recommendations
Priority Actions for Security Improvement
Enable DNSSEC on the domain to enhance DNS security and prevent spoofing.
✨Observations
AI-powered comprehensive website and business analysis.
AI-Enhanced Website Analysis
Business Insights
Taro Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries is a pharmaceutical company specializing in topical prescription products and other pharmaceutical offerings. It is now a privately held company wholly owned by Sun Pharma, a global healthcare company with innovative therapies, generic medicines, and consumer healthcare products.
good
consistent
Technical Stack
moderate
good
basic
basic
Security Assessment
- Domain status includes clientTransferProhibited and serverUpdate/Delete/TransferProhibited flags
Analytics & Tracking
Advertising & Marketing
Website Quality Assessment
Key Observations
Website is a corporate pharmaceutical site with clear business focus.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Weak X-Content-Type-Options configuration
LOWCurrent value: "nosniff, nosniff"
Missing Content-Security-Policy header
HIGHControls resources the browser is allowed to load
Missing X-XSS-Protection header
MEDIUMLegacy XSS protection (deprecated but still recommended)
Missing Referrer-Policy header
LOWControls referrer information sent with requests
Sensitive data may be cached
LOWCache-Control header should include "no-store" for sensitive pages
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
No Cookie Policy found
HIGHGDPR requires clear information about cookie usage
No Cookie Consent Banner found
HIGHGDPR requires explicit consent for non-essential cookies
No Data Protection Officer mentioned
LOWLarge organizations may need to designate a DPO under GDPR
Privacy policy may not be GDPR compliant
MEDIUMPrivacy policy lacks explicit GDPR compliance elements
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No information security framework found
HIGHNIS2 requires documented cybersecurity and information security measures
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No security policy documentation found
HIGHNIS2 requires documented cybersecurity governance and risk management
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No vulnerability reporting mechanism
MEDIUMClear vulnerability reporting supports coordinated disclosure
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Critical sector without clear security compliance
HIGHDetected sectors: transport, banking, health, digital
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
No MTA-STS Policy
MEDIUMMTA-STS enforces TLS for email delivery
No TLS-RPT Record
LOWTLS-RPT provides reporting for email TLS issues
SPF Details
DKIM Selectors Found
DMARC Details
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
Weak Protocols Supported
HIGHServer supports weak protocols: TLSv1.1
OCSP Stapling Not Enabled
LOWOCSP stapling improves performance and privacy
Certificate Transparency Not Implemented
LOWCertificate is not logged in Certificate Transparency logs
Mixed Content Detected
MEDIUM14 resources loaded over insecure HTTP
Partial SSL/TLS Assessment
LOWCompleted 3 of 4 security checks due to time constraints
Protocol Support
OCSP Status
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
DNSSEC Not Enabled
MEDIUMDNSSEC is not configured for this domain
CAA Records Not Configured
LOWCertificate Authority Authorization (CAA) records not found
DNS Records
DNSSEC Status
DNS Performance
SPF Analysis
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
Good Network Security Posture
LOWNo unnecessary services detected on common risky ports
🔧Technical Analysis
Detailed technical findings and analysis from AI assessment.
Technical Analysis
Comprehensive security assessment findings